Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:445-451

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Flem, L.
Right arrow Articles by Alhenc-Gelas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Flem, L.
Right arrow Articles by Alhenc-Gelas, M.
Related Collections
Right arrow Deep vein thrombosis
Right arrow Coagulation
Right arrow Thrombosis risk factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:445.)
© 2001 American Heart Association, Inc.


Thrombosis

Thrombomodulin Promoter Mutations, Venous Thrombosis, and Varicose Veins

Léna Le Flem; Louise Mennen; Marie-Laurence Aubry; Martine Aiach; Pierre-Yves Scarabin; Joseph Emmerich; Martine Alhenc-Gelas

From the Service d’Hématologie Biologique A and Service des Maladies Vasculaires (L.L.F., M.L.A., J.E., M.A., M.A.G.), Hôpital Européen Georges Pompidou, AP-HP and Unité INSERM 428, Faculté de Pharmacie, Université René Descartes, and Unité INSERM 258 (M.M., P.Y.S.), Paris, France.

Correspondence to Dr Martine Alhenc-Gelas, Service d’Hématologie Biologique A, Hôpital Européen Georges Pompidou, 20 rue Leblanc, F-75908 Paris Cedex 15, France. E-mail martine.alhenc-gelas{at}egp.ap-hop-paris.fr

Abstract—We analyzed the distal promoter region of the thrombomodulin (TM) gene (nucleotides -300 to -2052) in subjects from the Paris Thrombosis Study (PATHROS), a French case-control study of venous thrombosis, to identify polymorphisms that might modify TM gene expression. Eight novel mutations were found in the 40 DNA samples initially screened. Two of these mutations (-1748G/C and -1208/-1209 del TT) were frequent. One rare transition (-1166G/A) might have functional consequences owing to its position. These 3 mutations were screened for in the entire study population of 327 patients and 398 controls. None of the 3 was significantly associated with thrombosis. Interestingly, the -1208/-1209 TT deletion was associated with varicose veins in the patients. This mutation was in tight linkage disequilibrium with the +1418 C/T change in the coding sequence, a known polymorphism that predicts an Ala 455 Val substitution in the sixth epidermal growth factor–like TM module, a domain previously implicated in the proliferative functions of TM. This linkage suggests that the Ala 455 Val mutation may promote changes in these functions and thus be involved in varicose vein formation.


Key Words: thrombomodulin • thrombosis • coagulation • gene • angiogenesis




This article has been cited by other articles:


Home page
NeurologyHome page
S. Saiki, K. Sakai, M. Saiki, Y. Kitagawa, T. Umemori, K. Murata, M. Matsui, and G. Hirose
Varicose veins associated with CADASIL result from a novel mutation in the Notch3 gene.
Neurology, July 25, 2006; 67(2): 337 - 339.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M.-A. Pistorius
Chronic Venous Insufficiency: The Genetic Influence
Angiology, July 1, 2003; 54(1_suppl): S5 - S12.
[Abstract] [PDF]


Home page
BloodHome page
G. Kunz, A.-K. Ohlin, A. Adami, B. Zoller, P. Svensson, and D. A. Lane
Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function
Blood, May 15, 2002; 99(10): 3646 - 3653.
[Abstract] [Full Text] [PDF]